T
Thomas McGinn
Researcher at Hofstra University
Publications - 128
Citations - 12974
Thomas McGinn is an academic researcher from Hofstra University. The author has contributed to research in topics: Population & Health care. The author has an hindex of 35, co-authored 123 publications receiving 10091 citations. Previous affiliations of Thomas McGinn include Mount Sinai Hospital & Icahn School of Medicine at Mount Sinai.
Papers
More filters
Journal ArticleDOI
Impact of Clinical Decision Support on Antibiotic Prescribing for Acute Respiratory Infections: a Cluster Randomized Implementation Trial
Devin M. Mann,Rachel Hess,Thomas McGinn,Safiya Richardson,Simon Jones,Joseph Palmisano,Sara Kuppin Chokshi,Rebecca G. Mishuris,Lauren McCullagh,Linda Park,Catherine Dinh-Le,Paul D. Smith,David A Feldstein +12 more
TL;DR: The iCPR tool was not effective in reducing antibiotic prescription rates for upper respiratory infections in diverse primary care settings, which has implications for the generalizability of CDS tools as they are adapted to heterogeneous clinical contexts.
Journal ArticleDOI
Healthcare provider perceptions of clinical prediction rules
TL;DR: Healthcare providers describe clear preferences for certain clinical prediction rules, based on medical specialty, which are perceived as most useful by healthcare providers specialising in internal medicine and emergency medicine.
Journal ArticleDOI
Other Ways of Knowing.
Negin Hajizadeh,Melissa Basile,Andrzej Kozikowski,Meredith Akerman,Tara Liberman,Thomas McGinn,Michael A Diefenbach,Michael A Diefenbach +7 more
TL;DR: A range of emotional reactions to the information and frequent use of alternative knowledge frameworks for deriving meaning from the data led to insights into the impact of lived experiences on the uptake of biomedical information presented in decision aids.
Journal ArticleDOI
Hepatitis C treatment completion in individuals with psychiatric comorbidity and depression.
TL;DR: The results of this study concur with others that have shown that addressing behavioral health comorbidities concurrently with hepatitis C evaluation and treatment may improve treatment continuation rates among COMorbid patients, thereby helping to remove barriers to treatment of chronic hepatitis C.
Journal ArticleDOI
Factors Associated with Time to Follow-up of Severe Hyperkalemia in the Ambulatory Setting
TL;DR: Follow-up of abnormal laboratory results in outpatients is suboptimal and research is needed to better understand factors that delay follow-up.